In addition, limiting the number of infiltrating monocytes via CCR2 blockage has shown to decrease the infarct size in MI recovery animal models,37–39 demonstrating that the relevance of therapeutic approaches to limit infiltrating monocyte numbers is patients with increased systemic inflammatory activity to improve post-MI recovery. Here, CCR2 is linked to myocardial infarction.